RECIPROCAL PATTERN OF THE TSH AND PRL RESPONSES TO DOPAMINE RECEPTOR BLOCKADE IN WOMEN WITH PHYSIOLOGICAL OR PATHOLOGICAL HYPERPROLACTINAEMIA
- 1 February 1983
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 18 (2) , 103-110
- https://doi.org/10.1111/j.1365-2265.1983.tb03191.x
Abstract
The TSH and PRL [prolactin] responses to administration of the 2 dopamine (DA) receptor antagonists sulpiride and domperidone, were studied in 15 normoprolactinemic subjects, 22 post-partum women and 16 subjects with presumptive evidence of (6 subjects) or surgically confirmed (10 subjects) prolactinomas. Sulpiride (100 mg i.m.) or domperidone (10 mg i.v.) elicited a slight increase in basal TSH levels in both normoprolactinemic and post-partum women, but induced a clear-cut TSH rise in subjects with a tumor. Conversely, sulpiride and domperidone strikingly stimulated PRL secretion in normoprolactinemic and post-partum women, but only slightly enhanced baseline PRL levels in women with prolactinomas. The reason for the reciprocal pattern of TSH and PRL responsiveness to DA receptor blockade of post-partum women and subjects with prolactinomas is presently obscure. Since baseline PRL levels in the 2 hyperprolactinemic states overlapped widely, it would appear that hyperprolactinemia per se is not responsible for such behavior.This publication has 19 references indexed in Scilit:
- A new pharmacological approach to the diagnosis of hyperprolactinaemic states: the nomifensine testActa Endocrinologica, 1980
- Prolactin-Releasing Effect of Domperidone in Normoprolactinemic and Hyperprolactinemic SubjectsNeuroendocrinology, 1980
- Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activityBiochemical Pharmacology, 1979
- TESTS OF PROLACTIN SECRETION IN DIAGNOSIS OF PROLACTINOMASThe Lancet, 1979
- Inhibition of Gonadotropin and Prolactin Release by Dopamine: Effect of Endogenous Estradiol Levels*Journal of Clinical Endocrinology & Metabolism, 1978
- Loss of Central Nervous System Component of Dopaminergic Inhibition of Prolactin Secretion in Patients with Prolactin-Secreting Pituitary TumorsJournal of Clinical Investigation, 1978
- INCREASED PROLACTIN AND THYROTROPHIN SECRETION FOLLOWING ORAL METOCLOPRAMIDE: DOSE-RESPONSE RELATIONSHIPSClinical Endocrinology, 1977
- CLINICAL AND ENDOCRINE FEATURES OF HYPERPROLACTINAEMIC AMENORRHOEAClinical Endocrinology, 1976
- PLASMA THYROTROPHIN LEVELS DURING PREGNANCYBJOG: An International Journal of Obstetrics and Gynaecology, 1971
- New Tables for Multiple Comparisons with a ControlPublished by JSTOR ,1964